1. Home
  2. CBRE vs KVUE Comparison

CBRE vs KVUE Comparison

Compare CBRE & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBRE Group Inc

CBRE

CBRE Group Inc

HOLD

Current Price

$166.82

Market Cap

47.7B

Sector

Finance

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$16.74

Market Cap

33.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBRE
KVUE
Founded
1906
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Specialty Chemicals
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
47.7B
33.1B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
CBRE
KVUE
Price
$166.82
$16.74
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
$177.25
$20.00
AVG Volume (30 Days)
1.4M
32.8M
Earning Date
02-12-2026
02-05-2026
Dividend Yield
N/A
4.93%
EPS Growth
30.63
35.31
EPS
4.05
0.75
Revenue
$39,325,000,000.00
$15,006,000,000.00
Revenue This Year
$16.26
N/A
Revenue Next Year
$9.61
$2.81
P/E Ratio
$40.55
$22.50
Revenue Growth
14.61
N/A
52 Week Low
$108.45
$14.02
52 Week High
$171.00
$25.17

Technical Indicators

Market Signals
Indicator
CBRE
KVUE
Relative Strength Index (RSI) 63.34 42.08
Support Level $159.23 $16.93
Resistance Level $165.71 $17.42
Average True Range (ATR) 2.70 0.22
MACD 0.12 -0.07
Stochastic Oscillator 97.18 0.66

Price Performance

Historical Comparison
CBRE
KVUE

About CBRE CBRE Group Inc

CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: